PPIL1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 7.40518757424979E-14 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.54918308684182E-12 |
Normal-vs-Stage2 |
2.52564635871977E-12 |
Normal-vs-Stage3 |
3.05311331771918E-14 |
Normal-vs-Stage4 |
6.0507154842071E-13 |
Stage1-vs-Stage2 |
1.274840E-01 |
Stage1-vs-Stage3 |
6.116400E-02 |
Stage1-vs-Stage4 |
2.739400E-01 |
Stage2-vs-Stage3 |
9.031600E-01 |
Stage2-vs-Stage4 |
7.286000E-01 |
Stage3-vs-Stage4 |
6.007800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.68665081901054E-12 |
Normal-vs-AfricanAmerican |
1.68569602720936E-11 |
Normal-vs-Asian |
2.221700E-02 |
Caucasian-vs-AfricanAmerican |
9.344400E-01 |
Caucasian-vs-Asian |
6.375200E-01 |
AfricanAmerican-vs-Asian |
6.559800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.63369318073592E-12 |
Normal-vs-Female |
8.19533330087552E-12 |
Male-vs-Female |
3.820200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
9.64770041633756E-10 |
Normal-vs-Age(41-60Yrs) |
2.54685161849011E-13 |
Normal-vs-Age(61-80Yrs) |
8.1379347705024E-14 |
Normal-vs-Age(81-100Yrs) |
1.06099999896969E-08 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.883200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.006200E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.993800E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.570200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.146000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.020200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.46799999997971E-06 |
Normal-vs-Grade 2 |
1.66688884917221E-12 |
Normal-vs-Grade 3 |
1.64035451888367E-12 |
Normal-vs-Grade 4 |
1.69197988952874E-12 |
Grade 1-vs-Grade 2 |
9.209000E-01 |
Grade 1-vs-Grade 3 |
4.397600E-01 |
Grade 1-vs-Grade 4 |
3.371800E-01 |
Grade 2-vs-Grade 3 |
3.746200E-02 |
Grade 2-vs-Grade 4 |
4.260300E-02 |
Grade 3-vs-Grade 4 |
7.002200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.09898765035632E-12 |
Normal-vs-ccB subtype |
1.81965553736063E-12 |
ccA subtype-vs-ccB subtype |
4.123200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
2.79909428968494E-12 |
Normal-vs-N1 |
6.4065000000002E-05 |
N0-vs-N1 |
6.701200E-01 |
|
|